CD34 − /CD133 + /VEGFR-2 + Endothelial Progenitor Cell Subpopulation With Potent Vasoregenerative Capacities

Author:

Friedrich Erik B.1,Walenta Katrin1,Scharlau John1,Nickenig Georg1,Werner Nikos1

Affiliation:

1. From the Department for Internal Medicine III (E.B.F., K.W., J.S.), University Hospital of the Saarland; and Department for Internal Medicine II (G.N., N.W.), University Hospital Bonn, Germany.

Abstract

Our goal was to identify functionally important subpopulations within the heterogenous group of endothelial progenitor cells (EPC). Fluorescence-activated cell sorter analysis of CD133 + progenitor cells revealed the presence of CD34 + and CD34 subpopulations. CD34 /133 + progenitors differentiate into CD34 + /133 + EPC, adhere more potently than these in response to SDF-1, and rapidly home to sites of limb ischemia in human volunteers. In human coronary atherectomy samples, fewer CD34 /133 + than CD34 + /133 + EPC are present in stable plaques, whereas cell numbers increase with a reversion of the ratio in unstable lesions. In CD34 /133 + EPC-injected nude mice, more transplanted cells coexpressing endothelial markers home to carotid artery lesion endothelium than in CD34 + /133 + -injected mice. In the former, lesions were smaller and reendothelialization higher than in the latter. We identified a new CD34 /133 + EPC subpopulation, which is apparently a precursor of “classical” CD34 + /133 + EPC, and functionally more potent than these with respect to homing and vascular repair.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3